Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat

Martina Morokutti-Kurz, Christine Graf, Eva Prieschl-Grassauer Marinomed Biotechnologie GmbH, Vienna, Austria Abstract: Up to 80% of sore throats are caused by viruses. Several over the counter products are available which provide symptomatic, not causal relief. For such lozenges,...

Full description

Bibliographic Details
Main Authors: Morokutti-Kurz M, Graf C, Prieschl-Grassauer E
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/amylmetacresol24-dichlorobenzyl-alcohol-hexylresorcinol-or-carrageenan-peer-reviewed-article-IJGM
_version_ 1818318652841132032
author Morokutti-Kurz M
Graf C
Prieschl-Grassauer E
author_facet Morokutti-Kurz M
Graf C
Prieschl-Grassauer E
author_sort Morokutti-Kurz M
collection DOAJ
description Martina Morokutti-Kurz, Christine Graf, Eva Prieschl-Grassauer Marinomed Biotechnologie GmbH, Vienna, Austria Abstract: Up to 80% of sore throats are caused by viruses. Several over the counter products are available which provide symptomatic, not causal relief. For such lozenges, containing the antiseptics and local anesthetics amylmetacresol (AMC) and 2,4-dichlorobenzyl alcohol (DCBA) or hexylresorcinol (HR), recently an additional virucidal effect was published. Therefore, we tested a set of Strepsils® lozenges, containing either HR (Max [#2]) or AMC/DCBA (Original [#3], Extra Strong [#4], Warm [#5], Orange and Vitamin C [#6], Sugar free Lemon [#7], Children/Strawberry [#8] and Soothing Honey and Lemon [#9]) for their antiviral efficiency against representatives of respiratory viruses known to cause sore throat: human rhinovirus (HRV) 1a, HRV8, influenza virus A H1N1n, Coxsackievirus A10, and human coronavirus (hCoV) OC43. The lozenges were tested head to head with Coldamaris® lozenges (#1), which contain the patented antiviral iota-carrageenan. None of the tested AMC/DCBA or HR containing lozenges shows any antiviral effectiveness against HRV8 at the tested concentrations, whereas all are moderately active against HRV1a. Only lozenge #5 shows any activity against hCoV OC43 and Coxsackievirus A10 at the tested concentrations. Similarly, only lozenge #3 is moderately active against influenza A H1N1n virus. The data indicates that neither the isolated effect of the active ingredients nor the pH but rather one or more of the excipients of the specific formulations are responsible for the antiviral effect of some of the AMC/DCBA or HR containing lozenges. In contrast, carrageenan-containing lozenges are highly active against all viruses tested. In another experiment, we showed that binding and inactivation of virus particles by iota-carrageenan are fast and highly effective. During the residence time of the lozenge in the mouth, the viral titer is reduced by 85% and 91% for influenza A virus and hCoV OC43, respectively. Carrageenan-containing lozenges are, therefore, suitable as causative therapy against viral infections of the throat. Keywords: local anesthetics, polymer, antiviral, respiratory viruses
first_indexed 2024-12-13T09:56:38Z
format Article
id doaj.art-7a453a6e90894118ae42a4c6984abe79
institution Directory Open Access Journal
issn 1178-7074
language English
last_indexed 2024-12-13T09:56:38Z
publishDate 2017-02-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj.art-7a453a6e90894118ae42a4c6984abe792022-12-21T23:51:46ZengDove Medical PressInternational Journal of General Medicine1178-70742017-02-01Volume 10536031599Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throatMorokutti-Kurz MGraf CPrieschl-Grassauer EMartina Morokutti-Kurz, Christine Graf, Eva Prieschl-Grassauer Marinomed Biotechnologie GmbH, Vienna, Austria Abstract: Up to 80% of sore throats are caused by viruses. Several over the counter products are available which provide symptomatic, not causal relief. For such lozenges, containing the antiseptics and local anesthetics amylmetacresol (AMC) and 2,4-dichlorobenzyl alcohol (DCBA) or hexylresorcinol (HR), recently an additional virucidal effect was published. Therefore, we tested a set of Strepsils® lozenges, containing either HR (Max [#2]) or AMC/DCBA (Original [#3], Extra Strong [#4], Warm [#5], Orange and Vitamin C [#6], Sugar free Lemon [#7], Children/Strawberry [#8] and Soothing Honey and Lemon [#9]) for their antiviral efficiency against representatives of respiratory viruses known to cause sore throat: human rhinovirus (HRV) 1a, HRV8, influenza virus A H1N1n, Coxsackievirus A10, and human coronavirus (hCoV) OC43. The lozenges were tested head to head with Coldamaris® lozenges (#1), which contain the patented antiviral iota-carrageenan. None of the tested AMC/DCBA or HR containing lozenges shows any antiviral effectiveness against HRV8 at the tested concentrations, whereas all are moderately active against HRV1a. Only lozenge #5 shows any activity against hCoV OC43 and Coxsackievirus A10 at the tested concentrations. Similarly, only lozenge #3 is moderately active against influenza A H1N1n virus. The data indicates that neither the isolated effect of the active ingredients nor the pH but rather one or more of the excipients of the specific formulations are responsible for the antiviral effect of some of the AMC/DCBA or HR containing lozenges. In contrast, carrageenan-containing lozenges are highly active against all viruses tested. In another experiment, we showed that binding and inactivation of virus particles by iota-carrageenan are fast and highly effective. During the residence time of the lozenge in the mouth, the viral titer is reduced by 85% and 91% for influenza A virus and hCoV OC43, respectively. Carrageenan-containing lozenges are, therefore, suitable as causative therapy against viral infections of the throat. Keywords: local anesthetics, polymer, antiviral, respiratory viruseshttps://www.dovepress.com/amylmetacresol24-dichlorobenzyl-alcohol-hexylresorcinol-or-carrageenan-peer-reviewed-article-IJGMlocal anestheticspolymerantiviralrespiratory viruses
spellingShingle Morokutti-Kurz M
Graf C
Prieschl-Grassauer E
Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
International Journal of General Medicine
local anesthetics
polymer
antiviral
respiratory viruses
title Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
title_full Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
title_fullStr Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
title_full_unstemmed Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
title_short Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
title_sort amylmetacresol 2 4 dichlorobenzyl alcohol hexylresorcinol or carrageenan lozenges as active treatments for sore throat
topic local anesthetics
polymer
antiviral
respiratory viruses
url https://www.dovepress.com/amylmetacresol24-dichlorobenzyl-alcohol-hexylresorcinol-or-carrageenan-peer-reviewed-article-IJGM
work_keys_str_mv AT morokuttikurzm amylmetacresol24dichlorobenzylalcoholhexylresorcinolorcarrageenanlozengesasactivetreatmentsforsorethroat
AT grafc amylmetacresol24dichlorobenzylalcoholhexylresorcinolorcarrageenanlozengesasactivetreatmentsforsorethroat
AT prieschlgrassauere amylmetacresol24dichlorobenzylalcoholhexylresorcinolorcarrageenanlozengesasactivetreatmentsforsorethroat